Alfteimi Ammar, Zhao Yi, Lützen Ulf, Helm Alexander, Jüptner Michael, Zuhayra Maaz
Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Karl Lennert Cancer Center North, Feld-Str. 21, D-24105, Kiel, Germany.
EJNMMI Radiopharm Chem. 2025 May 4;10(1):21. doi: 10.1186/s41181-025-00343-w.
[F]Fallypride PET has been used to study D2/3 receptor occupancy and density in neuropsychiatric disorders including Huntington's disease (HD) and aging in humans. Nevertheless, the various synthetic methods including those provided by commercial synthesizers for [F]fallypride exhibit a disadvantage concerning the necessity of using a HPLC purification step, which causes difficulties in the automation, leads to long synthesis times and moderate yields. Therefore utilizing the purification step by SPE cartridges is considered highly desirable for future commercialization of radiopharmaceutical cassettes. In our lab we have developed a simplified reliable automatic Radiosynthesis of [F]fallypride by using SPE cartridges for the purification step without the need of HPLC.
A simplified Radiosynthesis of [F]fallypride has been developed without the use of HPLC for both a commercial cassette based synthesis system (AllinOne (AiO) system, Trasis, Belgium) and a research synthesis module with fixed tubing (RNplus, Synthra, Germany). The cleaning step involves a serial combination of several SPE cartridges. The synthesis time was shortened by 44% compared to synthesis using HPLC. At the same time the not decay corrected yield increases from 44 to 59% by using TBAHCO as phase transfer catalysts and from 17 to 31% for the synthesis with KCO/Kryptofix-[2.2.2] compared to synthesis using HPLC. The Radiochemical purity was always > 98% and all quality control parameters (e.g. sterility, endotoxin, stability and Radiochemical purity) conformed with requirements of the European Pharmacopoeia.
A GMP compliant automatic synthesis of [F]fallypride including purification using simple solid phase extraction cartridges instead of HPLC was developed and evaluated. The implementation of the simplified synthesis in both used commercial modules allows efficient and reproducible Radiosynthesis of [F]fallypride and leads to short synthesis times and high radiochemical yields with high radiochemical purity.
[F]氟哌利多正电子发射断层扫描(PET)已被用于研究神经精神疾病(包括亨廷顿舞蹈症(HD))和人类衰老过程中的D2/3受体占有率及密度。然而,包括商业合成仪提供的合成[F]氟哌利多的各种方法,在使用高效液相色谱(HPLC)纯化步骤方面存在缺点,这给自动化带来困难,导致合成时间长且产率中等。因此,利用固相萃取(SPE)柱进行纯化步骤被认为对放射性药物盒的未来商业化非常有利。在我们实验室,我们已经开发出一种简化且可靠的[F]氟哌利多自动放射性合成方法,该方法使用SPE柱进行纯化步骤,无需HPLC。
已开发出一种简化的[F]氟哌利多放射性合成方法,该方法在基于商业盒式合成系统(AllinOne(AiO)系统,比利时特拉斯公司)和具有固定管路的研究合成模块(RNplus,德国辛特拉公司)中均无需使用HPLC。清洗步骤包括几个SPE柱的串联组合。与使用HPLC的合成相比,合成时间缩短了44%。同时,使用碳酸氢叔丁铵(TBAHCO)作为相转移催化剂时,未衰变校正产率从44%提高到59%,使用碳酸钾/穴醚[2.2.2]合成时,产率从17%提高到31%,相比使用HPLC的合成。放射化学纯度始终>98%,所有质量控制参数(如无菌性、内毒素、稳定性和放射化学纯度)均符合欧洲药典的要求。
开发并评估了一种符合药品生产质量管理规范(GMP)的[F]氟哌利多自动合成方法,该方法使用简单的固相萃取柱而非HPLC进行纯化。在两种使用的商业模块中实施简化合成,可实现高效且可重复的[F]氟哌利多放射性合成,并导致合成时间短、放射化学产率高且放射化学纯度高。